Janus Henderson Group plc 13D and 13G filings for Ligand Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:36 pm Purchase |
2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,015,023 5.400% |
5,929 (+0.59%) |
Filing |
| 2024-11-14 3:19 pm Sale |
2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,009,094 5.500% |
-334,060 (-24.87%) |
Filing |
| 2024-02-13 3:39 pm Purchase |
2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,343,154 7.700% |
87,881 (+7.00%) |
Filing |
| 2023-02-10 3:23 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,255,273 7.400% |
-1,054,786 (-45.66%) |
Filing |
| 2022-02-10 4:35 pm Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
2,310,059 8.600% |
-274,568 (-10.62%) |
Filing |
| 2021-02-11 4:42 pm Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
2,584,628 10.000% |
-376,450 (-12.71%) |
Filing |